Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus. - Wikidata - wikimedia - TriplyDB

Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.

Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.

http://www.wikidata.org/entity/Q41570947

about

Evolution of resistance to a last-resort antibiotic in Staphylococcus aureus via bacterial competition Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates Mechanisms of vancomycin resistance in Staphylococcus aureus Structure, Bioactivity, and Resistance Mechanism of Streptomonomicin, an Unusual Lasso Peptide from an Understudied Halophilic Actinomycete Intermediate-type vancomycin resistance (VISA) in genetically-distinct Staphylococcus aureus isolates is linked to specific, reversible metabolic alterations.Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.Community-associated methicillin-resistant Staphylococcus aureus case studies.Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus.Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility Reversible antibiotic tolerance induced in Staphylococcus aureus by concurrent drug exposure.[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].The Eukaryotic-Like Ser/Thr Kinase PrkC Regulates the Essential WalRK Two-Component System in Bacillus subtilis Evolving resistance among Gram-positive pathogens Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus.Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression.Novel Mutation Sites in the Development of Vancomycin- Intermediate Resistance in Staphylococcus aureus.Genome sequence-based discriminator for vancomycin-intermediate Staphylococcus aureus.Genetic engineering of a temperate phage-based delivery system for CRISPR/Cas9 antimicrobials against Staphylococcus aureus.Vancomycin therapeutics and monitoring: a contemporary approach.The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infection.Novel Observations in 11 Heteroresistant Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Strains from South India.Reduced Vancomycin Susceptibility of Methicillin-Susceptible Staphylococcus aureus Has No Significant Impact on Mortality but Results in an Increase in Complicated Infection.Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis.Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia.Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS.VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA.Reduced vancomycin susceptibility in porcine ST9 MRSA isolates.Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost.Induction of Immunosuppressive CD8+CD25+FOXP3+ Regulatory T Cells by Suboptimal Stimulation with Staphylococcal Enterotoxin C1.Actinorhodin is a redox-active antibiotic with a complex mode of action against Gram-positive cells.Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility.Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.Distribution of the Most Prevalent Spa Types among Clinical Isolates of Methicillin-Resistant and -Susceptible Staphylococcus aureus around the World: A Review.

P2860

Q24490083-DF50FC54-D212-45DE-8E1B-108BFF88D1CB Q26796560-3EF0D250-6C35-4E57-A6E0-3A81D5FE5B68 Q26829312-B51B0F70-B51C-472E-B483-66025F2FA340 Q27644318-67332145-809A-4D84-AE6F-E10B7E0A410A Q33591402-73402B23-3ED2-41FE-8992-BF29863ABD19 Q33696380-C771E05C-7FED-4F7C-810D-B1A10C9FC507 Q33792021-446BB7DC-095C-409A-A51A-1759EEF4954E Q34057324-30F66123-25A7-427D-8990-0ADCFAFC00FA Q34343212-3887EA28-778B-42CE-8337-7F29550BBBED Q34632683-D519B5F0-7CF7-40B2-A23A-B17E48FF3749 Q35038242-AFE333DC-C514-4880-9016-6BF9C7B9D006 Q35619094-63F6A773-C1E1-48CC-A0F1-88F7E8801706 Q35671883-D79DC1C6-20F0-456E-B4B2-AB2E26554F05 Q35999912-89184511-121F-46BD-941B-26A43B66608B Q36116970-3DB8DC79-3FD2-4A3C-9332-D2410D40AE8F Q36882486-E2AFA82B-1F56-4DE0-B872-156105F2203B Q36969754-96F92F60-5CB5-4DF1-B587-3ADFCB66DC33 Q37575024-89E25700-59DD-4528-82F4-366A8FCA36B3 Q37643403-AF73848B-62D2-470A-847D-E57F7CF22EAB Q37712935-17F1F700-FD22-40CA-AEE4-63AAEFD6DBC0 Q38062923-F699C4FA-18BF-4883-A9E1-BA6B9031E8C7 Q38130513-27AD174E-FF68-4A0B-A3FB-E31D695EECE9 Q39743944-200BAD8E-9A3C-4F1F-8551-C0DDC88B611A Q40200466-54CB6F52-F11F-4844-BF59-7744D528F346 Q40896611-DE10DFD5-F4E3-4720-BB1D-A5601FB819B9 Q41087225-259DC036-1BD4-43BF-817A-C3FF8DD03375 Q42202739-8F8A7FF9-156C-4777-BF1F-C8BBBD763019 Q42358800-D2DEEE4C-E45B-4946-8A69-3A6D0D674AE4 Q42905367-07DE91AA-A89C-480D-AE74-1C18153D4897 Q47116570-A1822365-D723-4458-A1D9-B2A2E8D5B523 Q47252494-FA4AE266-3C73-46C3-910A-3454DDDED061 Q47804224-409D6D20-F186-482B-B946-252FC201847E Q50132676-E16CE420-3C73-49DF-B142-6F29AF063270 Q50195416-FE194216-8C8C-4DD1-92FA-8978234258C2 Q50327973-0B1D0A02-B2AC-4E04-BA41-4D0C125EC2E3

P2860

Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.

http://www.wikidata.org/entity/Q41570947

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Contribution of selected gene ...... mediate Staphylococcus aureus.

@en

type

label

Contribution of selected gene ...... mediate Staphylococcus aureus.

@en

prefLabel

Contribution of selected gene ...... mediate Staphylococcus aureus.

@en

P1433

Q41570947-51ECA51B-1C9E-41DB-B142-7E7E315D04DA

P1476

Q41570947-3CBB77CB-F14E-4911-A22B-3669F0A5FED9

P2093

Q41570947-01BAAB4D-D2F6-4424-85E4-DE1CD864A226

Q41570947-53CD9999-A4C8-429D-9921-557F59A1E444

Q41570947-5E7C4B26-8EF8-4D3D-9F76-32F515B67FD0

Q41570947-97A127F5-D8CE-4030-A512-9C5E59491737

Q41570947-EBC3A49A-EF97-4D84-9050-CB291B9D5A06

P2860

Q41570947-03C466DC-206B-4BAF-A08F-39A7BC302F1F

Q41570947-0C278413-412D-4088-BCEB-D48B07AF62DC

Q41570947-1A30A655-B462-43D5-A5F2-F8360AEC4857

Q41570947-1F5F6991-6229-469E-9B10-F1428F192D52

Q41570947-24D85FA3-33F1-4997-94EF-23637C36B62A

Q41570947-2D323AC0-3416-47D3-B8CA-7C2A08BE3996

Q41570947-32B8359A-8B27-45FA-B93E-D43336F37BDD

Q41570947-3723A394-35B4-450F-9234-54E081B02871

Q41570947-4A5916DE-489C-45A9-BB51-831DDDDE649A

Q41570947-4FD50549-4141-4A3A-95CC-73CD2DD12072

P304

Q41570947-4FAC8384-52EA-4436-A135-C8C91964EB1C

P31

Q41570947-F1389C06-CE56-494A-BC18-1D96AF30E37E

P356

Q41570947-3C1A453B-6473-4661-8130-B4DFF4A8471D

P407

Q41570947-8490501B-6A15-44F9-910F-5E955CD690A4

P433

Q41570947-1AA98AF7-2B6A-4951-A44B-D82947C685C8

P478

Q41570947-52FB3DC3-8F4E-4B18-BC83-3F928585ECAB

P577

Q41570947-12DF2BED-DC0E-4D3D-9F54-2A04A4F6DB0C

P5875

Q41570947-761A48CB-F641-4D19-8AC1-6D70748E29B7

P698

Q41570947-9D0A5A2E-08A4-4107-B230-912F42BBADFA

P932

Q41570947-B8881B20-BC1C-4734-89AA-BD04D3913994

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Contribution of selected gene ...... mediate Staphylococcus aureus.

@en

P2093

Anne-Catrin Uhlemann

http://www.w3.org/2001/XMLSchema#string

Cory Hafer

http://www.w3.org/2001/XMLSchema#string

Franklin D Lowy

http://www.w3.org/2001/XMLSchema#string

John Kornblum

http://www.w3.org/2001/XMLSchema#string

Ying Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications

Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR

The environment as an unrecognized reservoir for community-associated methicillin resistant Staphylococcus aureus USA300: a case-control study

Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus

Based Upon Repeat Pattern (BURP): an algorithm to characterize the long-term evolution of Staphylococcus aureus populations based on spa polymorphisms

International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009.

Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin

Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing.

Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management.

Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherap

P304

5845-5851

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01139-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230797773

http://www.w3.org/2001/XMLSchema#string

P698

22948864

http://www.w3.org/2001/XMLSchema#string

P932

3486570

http://www.w3.org/2001/XMLSchema#string